![Michael Sailor](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Sailor
Founder at Impilo Therapeutics, Inc.
Michael Sailor active positions
Companies | Position | Start | End |
---|---|---|---|
Impilo Therapeutics, Inc.
![]() Impilo Therapeutics, Inc. Packaged SoftwareTechnology Services Impilo Therapeutics, Inc. engages in the development of platform for delivering nucleic acid-based medicines to solid tumor cancers. The company was founded by Sangeeta N. Bhatia, Frank J. Slack, and Michael Sailor and is headquartered in San Diego, CA. | Founder | - | - |
Cend Therapeutics, Inc.
![]() Cend Therapeutics, Inc. BiotechnologyHealth Technology Cend Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapies for solid tumor cancers. Its offers CendR Platform, which provides a targeted tissue penetration capability to specifically enhance drug delivery to tumors. Its lead compound CEND-1 seeks out tumors and activates the CendR transport pathway. The company was founded by Erkki Ruoslahti in 2016 and is headquartered in San Diego, CA. | Director/Board Member | 21/09/2020 | - |
Career history of Michael Sailor
Statistics
International
United States | 3 |
Operational
Founder | 1 |
Director/Board Member | 1 |
Sectoral
Health Technology | 2 |
Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Cend Therapeutics, Inc.
![]() Cend Therapeutics, Inc. BiotechnologyHealth Technology Cend Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapies for solid tumor cancers. Its offers CendR Platform, which provides a targeted tissue penetration capability to specifically enhance drug delivery to tumors. Its lead compound CEND-1 seeks out tumors and activates the CendR transport pathway. The company was founded by Erkki Ruoslahti in 2016 and is headquartered in San Diego, CA. | Health Technology |
Impilo Therapeutics, Inc.
![]() Impilo Therapeutics, Inc. Packaged SoftwareTechnology Services Impilo Therapeutics, Inc. engages in the development of platform for delivering nucleic acid-based medicines to solid tumor cancers. The company was founded by Sangeeta N. Bhatia, Frank J. Slack, and Michael Sailor and is headquartered in San Diego, CA. | Technology Services |
- Stock Market
- Insiders
- Michael Sailor
- Experience